Physician profile
Eric Kung
NPI 1639262686
$83,234.91
in general payments reported to CMS, 2019-2025
17 companies · $6,600 in 2025
The $6,600 reported for 2025 was more than what 87% of Neurology (Psychiatry & Neurology) providers received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $507 · 2020: $13K · 2021: $26K · 2022: $17K · 2023: $12K · 2024: $6,747 · 2025: $6,600.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $24K · Food and Beverage: $2,047 · Education: $108.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $23,550.00 |
| Food and Beverage | $2,047.11 |
| Education | $107.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $51,222.07 | 2021-2025 | |
| Allergan, INC. | $15,127.71 | 2020-2021 | |
| Biohaven Pharmaceuticals, INC. | $7,899.44 | 2021 | |
| Biohaven Pharmaceutical Holding Company Ltd. | $7,194.55 | 2022 | |
| Lundbeck LLC | $348.94 | 2023-2025 | Vyepti |
| Pfizer INC. | $275.74 | 2023-2025 | |
| Amgen INC. | $222.90 | 2019-2020 | |
| Impel Pharmaceuticals INC. | $222.83 | 2023 | Trudhesa |
| Genentech USA, INC. | $139.14 | 2019 | |
| Genzyme Corporation | $125.00 | 2019 | |
| Promius Pharma LLC | $107.95 | 2019 | |
| Lilly USA, LLC | $102.14 | 2022 | |
| Vertex Pharmaceuticals Incorporated | $91.78 | 2025 | |
| Tonix Medicines, INC. | $79.72 | 2025 | Zembrace Symtouch |
| Axsome Therapeutics, INC. | $31.63 | 2025 | Symbravo |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $25.37 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $18.00 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Kung listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.